Solventum (SOLV) Net Income Quarterly: History & Chart

Solventum Corporation(SOLV)

Medical - Instruments & Supplies · Eagan, MN

$89.20-0.83 (-0.92%)

Delayed quote: Sep 10, 2026, 10:15 AM EDT

About Solventum Corporation

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Eagan, MN

20,584 employees

www.solventum.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Bryan C. Hanson

View full financials

Quarterly Net Income

Basis: latest reported fiscal quarter. Source: stored company filings; unavailable inputs remain N/A.

The latest quarterly net income is $92.00M. Quarterly net income is profit after expenses, taxes, interest, and other items for the latest fiscal quarter.

Net Income TTM|Net Income CAGR|Profit Margin|Financials

Quarterly Net Income

SOLV Quarterly Net Income

$92.00M

Reported quarterly net income; no daily interpolation. Q2 FY2026 (2026-06-30): $92.00M.

-73.75% over 10Y

SOLV P/E Ratio

Full P/E Ratio page

P/E Ratio

SOLV P/E Ratio Chart

10.94

FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-10T14:20:00.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.

SOLV Earnings Yield

Full Earnings Yield page

Earnings Yield

SOLV Earnings Yield Chart

9.14%

Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-10T14:20:00.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.

Quarterly Net Income History

Period	Quarterly Net Income	QoQ Growth	YoY Growth
Q2 FY2026Period end 2026-06-30	$92.00M	N/A	+2.22%
Q1 FY2026Period end 2026-03-31	$13.00M	(79.37%)	(90.51%)
Q4 FY2025Period end 2025-12-31	$63.00M	(95.02%)	+103.23%
Q3 FY2025Period end 2025-09-30	$1.27B	+1306.67%	+937.70%
Q2 FY2025Period end 2025-06-30	$90.00M	(34.31%)	+1.12%
Q1 FY2025Period end 2025-03-31	$137.00M	+341.94%	(42.19%)
Q4 FY2024Period end 2024-12-31	$31.00M	(74.59%)	(88.60%)
Q3 FY2024Period end 2024-09-30	$122.00M	+37.08%	(73.48%)
Q2 FY2024Period end 2024-06-30	$89.00M	(62.45%)	(72.27%)
Q1 FY2024Period end 2024-03-31	$237.00M	(12.87%)	(19.11%)
Q4 FY2023Period end 2023-12-31	$272.00M	(40.87%)	N/A
Q3 FY2023Period end 2023-09-30	$460.00M	+43.30%	+37.31%
Q2 FY2023Period end 2023-06-30	$321.00M	+9.56%	(8.42%)
Q1 FY2023Period end 2023-03-31	$293.00M	N/A	(16.41%)
Q4 FY2022Period end 2022-12-31	($316.00M)	N/A	N/A
Q3 FY2022Period end 2022-09-30	$335.00M	(4.42%)	N/A
Q2 FY2022Period end 2022-06-30	$350.50M	+0.00%	N/A
Q1 FY2022Period end 2022-03-31	$350.50M	N/A	N/A

Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.